Home    Back

Cerazette    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
230Alveolar hypoventilation syndrome1

230. Alveolar hypoventilation syndrome    [ 8 clinical trials,   11 drugs,   (DrugBank: 5 drugs),   18 drug target genes,   27 drug target pathways]
Searched query = "Alveolar hypoventilation syndrome", "AHS", "Hypoventilation syndrome", "OHS", "CCHS", "Idiopathic central alveolar hypoventilation", "ICAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 8 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2011-000989-35-FR
(EUCTR)		06/05/2011N/AN/A - RESPIRONDINE
MedDRA version: 14.0;Level: PT;Classification code 10066131;Term: Congenital central hypoventilation syndrome;System Organ Class: 10010331 - Congenital, familial and genetic disorders		Trade Name: Cerazette
Product Name: Cerazette
INN or Proposed INN: Désogestrel		ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNAFemale: yes
Male: no		Phase 2France